Lesson from Real-World Experience: Optimal Treatment with Anti-Tumor Necrosis Factor for Ulcerative Colitis
Gut Liver
.
2021 Nov 15;15(6):793-794.
doi: 10.5009/gnl210512.
Author
Jaeyoung Chun
1
Affiliation
1
Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
PMID:
34782487
PMCID:
PMC8593503
DOI:
10.5009/gnl210512
No abstract available
Publication types
Editorial
MeSH terms
Colitis, Ulcerative* / drug therapy
Humans
Infliximab
Treatment Outcome
Tumor Necrosis Factor-alpha
Substances
Tumor Necrosis Factor-alpha
Infliximab